U.S. cannabis company is entering the burgeoning European cannabis market through a deal to acquire Emmac Life Sciences. The $286 million acquisition grants Curaleaf valuable exposure to a growing market. Curaleaf CEO Joe Bayern joined Cheddar to discuss.